Industry:Biotech & Pharma
Callisto Pharmaceuticals Inc
Callisto Pharmaceuticals Inc (CLSP:US)
was acquired by SGYP:US
Callisto Pharmaceuticals Inc. is a drug development company focused on the clinical development of drugs to treat cancer. The company's most advanced drug candidate is Annamycin, an anthracycline for the treatment of relapsed leukemias. Callisto's other products being developed include Atiprimod, for relapsed multiple myeloma and bone resorption.